Tuesday, January 27, 2009

Targin (oral oxycodone/naloxone prolonged-release tablet) now launching across Europe to control severe chronic pain with reduced risk of constipation

26 January 2009 - Mundipharma today announced that 13 countries to date have received approval of Targin, a new combination therapy designed to control severe chronic pain whilst counteracting opioid-induced constipation, a common and often debilitating side effect associated with opioid treatment.1,2,3 A period of European launches will now be initiated.

The details can be read here.

No comments: